Pharmacokinetics and hemodynamic effects of diltiazem in healthy volunteers: Comparing resting with the effect of exercise

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 8, 1999, Pages 413-416

  Yeung, P K F ^a,b   Hung, O R ^a   Pollak, P T ^a   Klassen, G A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Diltiazem; Healthy volunteers; Hemodynamics; Pharmacokinetics

Indexed keywords

CORONARY VASODILATING AGENT; DILTIAZEM;

ADULT; ARTERIAL PRESSURE; ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

ADULT; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; EXERCISE; FEMALE; HEART RATE; HUMANS; MALE; REST;

EID: 0032802308     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bruce R 1971 Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res 3: 323-332
2. Downing SJ, Edwards D, Hollingsworth M 1987 Diltiazem pharmacokinetics in the rat and the relationship between its serum concentration and uterine and cardiovascular effects. Br J Pharmacol 91: 735-745
3. Gordin A, Pohto P, Sundberg S, Nykanen S, Haataja H, Mannisto P 1986 Pharmacokinetics of slow-release diltiazem and its effect on atrioventricular conduction in healthy volunteers. Eur J Clin Pharmcol 31: 423-426
4. Joyal M, Pieper J, Cremer K, Feldman R, Pepine C 1986 Pharmacodynamic aspects of intravenous diltiazem administration. Am Heart J 111: 54-61
5. Kinney EL, Moskowitz RM, Zelis R 1981 The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers. J Clin Pharmacol 21: 337-342
6. Klassen G, Yeung P, Barclay K, Hung O, Pollak P, Buckley S 1995 Gender differences in exercise and recovery blood pressure responses in normal volunteers given diltiazem. J Clin Pharmacol 35: 1144-1149
7. Medical Letter 1997 Safety of calcium channel blockers. Med Lett 39: 13-16
8. Schwartz JB, Abernethy DR 1987 Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension. Am J Cardiol 59: 1111-1117
9. Smith MS, Verghese CP, Shand DG, Pritchett ELC 1983 Pharmacokinetic and pharmacodynamic effects of diltiazem. Am J Cardiol 51: 1369-1374
10. Tsui B, Feng J, Yeung P 1998 Pharmacokinetics and haemodynamic effects of diltiazem in rats: Effect of route of administration. J Pharm Pharmacol 50: 183-188
11. Weir M 1995 Diltiazem: Ten years of clinical experience in the treatment of hypertension. J Clin Pharmacol 35: 220-232
12. Yabana H, Nagao T, Sato M 1985 Cardiovascular effects of the metabolites of diltiazem in dogs. J Cardiovasc Pharmacol 7: 152-157
13. Yeung PKF, Montague TJ, Tsui B, McGregor C 1989 High performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: Application to a pharmacokinetic study in healthy volunteers. J Pharm Sci 78: 592-597
14. Yeung PKF, Mosher SJ, MacRae DA, Klassen GA 1991 Effect of diltiazem and its metabolites on the uptake of adenosine in blood: An in-vitro investigation. J Pharm Pharmacol 43: 685-689
15. Yeung P, Feng J, Buckley S 1998a Pharmacokinetics and hypotensive effect of diltiazem in rabbits: comparing diltiazem to its major metabolites. J Pharm Pharmacol 50: 1247-1253
16. Yeung PKF, Feng JDZ, Klassen GA 1998b Pharmacokinetics and pharmacodynamics of diltiazem: Species differences. Pharm Sci Suppl 1: S-669